Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects
Abstract Acute coronary syndromes, such as myocardial infarction (MI), lack effective therapies beyond heart transplantation, which is often hindered by donor scarcity and postoperative complications. Human induced pluripotent stem cells (hiPSCs) offer the possibility of myocardial regeneration by d...
| Үндсэн зохиолчид: | , , , , , , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | English |
| Хэвлэсэн: |
BMC
2024-10-01
|
| Цуврал: | Stem Cell Research & Therapy |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1186/s13287-024-03961-4 |